DiaMedica Therapeutics (DMAC) Stock Chart & Stock Price History $4.03 -0.09 (-2.18%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$4.03 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DiaMedica Therapeutics Stock Price Performance The DiaMedica Therapeutics (DMAC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 60.56%, with a year-to-date return of -25.78%. In the past month, the stock has increased 5.22%, reflecting recent market activity. As of the latest close, DiaMedica Therapeutics traded at $4.03 with a market cap of $172.82 million and volume of 68,588 shares. Five years ago, the stock traded at $4.68, representing a 13.89% decrease over that period. At the time, it had a market cap of $64.90 million and a volume of 40,902 shares. Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.66%1 Month Performance+5.22%3 Month Performance-30.52%Year-To-Date Performance-25.78%1 Year Performance+60.56%5 Year Performance-13.89% DMAC Stock Chart for Thursday, June, 12, 2025 DMAC Chart by TradingView DiaMedica Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$4.12$4.03-2.18%$4.25$4.0368,588 shs$172.82 million06/10/2025$4.08$4.12+0.98%$4.28$4.0875,483 shs$176.68 million06/09/2025$4.14$4.08-1.45%$4.24$4.06111,635 shs$174.96 million06/06/2025$4.09$4.14+1.22%$4.33$4.02124,071 shs$177.54 million06/05/2025$4.20$4.09-2.62%$4.31$4.07108,165 shs$175.39 million06/04/2025$4.12$4.20+1.94%$4.46$4.15183,684 shs$180.11 million06/03/2025$4.17$4.12-1.20%$4.26$4.05166,026 shs$176.68 million06/02/2025$4.10$4.17+1.71%$4.26$4.0697,855 shs$178.82 million05/30/2025$4.19$4.10-2.15%$4.26$4.0089,854 shs$175.82 million05/29/2025$4.16$4.19+0.72%$4.32$4.0784,526 shs$179.68 million Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$4.15$4.16+0.24%$4.33$4.1086,687 shs$178.39 million05/27/2025$4.06$4.15+2.22%$4.32$4.10135,437 shs$177.96 million05/26/2025$4.06$4.06$4.23$4.0080,803 shs$174.11 million05/23/2025$4.05$4.06+0.25%$4.23$4.0080,803 shs$174.11 million05/22/2025$4.13$4.05-1.94%$4.16$3.9278,186 shs$173.68 million05/21/2025$4.14$4.13-0.24%$4.30$3.96101,751 shs$177.11 million05/20/2025$4.27$4.14-3.04%$4.27$4.12116,063 shs$177.54 million05/19/2025$4.20$4.27+1.67%$4.46$4.10162,524 shs$183.11 million05/16/2025$4.07$4.20+3.19%$4.28$3.82100,771 shs$180.00 million05/15/2025$4.00$4.07+1.75%$4.23$3.89115,885 shs$174.42 million05/14/2025$3.98$4.00+0.50%$4.31$3.91210,892 shs$171.42 million05/13/2025$3.83$3.98+3.92%$4.07$3.76108,247 shs$170.57 million05/12/2025$3.76$3.83+1.86%$3.95$3.65115,537 shs$164.14 million Related Companies Day One Biopharmaceuticals Stock Price Chart Vir Biotechnology Stock Price Chart Anavex Life Sciences Stock Price Chart Arbutus Biopharma Stock Price Chart Evolus Stock Price Chart KalVista Pharmaceuticals Stock Price Chart AnaptysBio Stock Price Chart Cogent Biosciences Stock Price Chart AbCellera Biologics Stock Price Chart Trevi Therapeutics Stock Price Chart Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMAC) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DMAC Stock Free DMAC Stock Alerts